Gemmer Asset Management’s Core Laboratories CLB Stock Holding History

Gemmer Asset Management’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-219	Closed	-$6K	–	290
2022 Q1	$6K	Hold	219	–	–	﹤0.01%	863
2021 Q4	$5K	Hold	219	–	–	﹤0.01%	965
2021 Q3	$6K	Hold	219	–	–	﹤0.01%	879
2021 Q2	$9K	Hold	219	–	–	﹤0.01%	815
2021 Q1	$6K	Hold	219	–	–	﹤0.01%	956
2020 Q4	$6K	Hold	219	–	–	﹤0.01%	881
2020 Q3	$3K	Sell	219 -155	-41%	-$3.25K	﹤0.01%	1040
2020 Q2	$8K	Buy	374 +179	+92%	+$3.21K	﹤0.01%	665
2020 Q1	$2K	Buy	195 +143	+275%	+$4K	﹤0.01%	1037
2019 Q4	$2K	Buy	+52	New	+$2.34K	﹤0.01%	1228
2019 Q2	–	Sell	-33	Closed	-$2K	–	1377
2019 Q1	$2K	Sell	33 -27	-45%	-$1.81K	﹤0.01%	1256
2018 Q4	$4K	Sell	60 -15	-20%	-$1.29K	﹤0.01%	975
2018 Q3	$9K	Hold	75	–	–	﹤0.01%	742
2018 Q2	$9K	Buy	75 +1	+1%	+$122	﹤0.01%	741
2018 Q1	$8K	Buy	74 +32	+76%	+$3.54K	﹤0.01%	771
2017 Q4	$5K	Sell	42 -17	-29%	-$1.7K	﹤0.01%	953
2017 Q3	$6K	Buy	+59	New	+$5.72K	﹤0.01%	873

Other funds holding CLB

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Gemmer Asset Management's CLB Position: Q2 2022 in Review

Gemmer Asset Management sold out of Core Laboratories (CLB) in Q2 2022, closing a stake of 219 shares — an estimated $6K sold.

Gemmer Asset Management first reported a position in CLB in Q3 2017 and held it in 17 quarters. The position peaked at $9K in Q2 2021. 175 funds tracked by Wall St. Rank hold CLB as of Q2 2022.

Gemmer Asset Management reported no remaining Core Laboratories position as of Q2 2022 after selling out during the quarter.
Gemmer Asset Management sold 219 Core Laboratories shares in Q2 2022, an estimated $6K.
Gemmer Asset Management first reported a position in Core Laboratories in Q3 2017 and held it in 17 quarters.
Gemmer Asset Management's Core Laboratories position peaked at $9K in Q2 2021.
175 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2022.

Based on Gemmer Asset Management's 13F filing for Q2 2022, filed 22 Jul 2022.